Abdullah Kisaoglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Abdullah Kisaoglu has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Bulent Aydinli
Akdeniz University Faculty of Medicine, Department of General Surgery, Antalya, Türkiye
8 shared publications - Ismail Demiryilmaz
Department of General Surgery, Akdeniz University Faculty of Medicine, Antalya, Türkiye
6 shared publications - Vural Taner Yilmaz
Division of Nephrology, Faculty of Medicine, Department of Internal Medicine, Akdeniz University, Antalya, Türkiye
6 shared publications Bunyami Ozogul
5 shared publications- Gurkan Ozturk
Department of General Surgery, Atatürk University Faculty of Medicine, Erzurum, Türkiye
5 shared publications - Ali Avanaz
Department of General Surgery, Faculty of Medicine, Akdeniz University, Antalya, Turkey
4 shared publications
Latest Publications
- 18 August 2026
- Published by Elsevier in Transplantation Proceedings
Long-Term Outcomes of Renal Transplantation in Patients with Cystinosis
- 18 August 2026
- Published by Elsevier in Transplantation Proceedings
Long-Term Outcomes of Renal Transplantation in Patients with Cystinosis
- Open Access
- 25 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
The effects of splenectomy, platelet-rich plasma (PRP) and concentrated growth factor (CGF) on liver regeneration following major hepatectomy in rats
Post-hepatectomy liver failure is a serious complication following liver resection and is associated with high morbidity and mortality. Platelets play a crucial role in liver regeneration due to their rich content of growth factors. However, the comparative effects of platelet-rich plasma (PRP) and concentrated growth factor (CGF) on liver regeneration remain unclear. This study aimed to evaluate and compare the effects of splenectomy (SPx), PRP, and CGF on liver regeneration and function following 70% hepatectomy in rats. Male Wistar rats were randomly divided into six groups: Control, Sham, Hepatectomy (PHx), Hepatectomy + SPx, Hepatectomy + PRP, and PHx + CGF. PRP and CGF were prepared using differential centrifugation and administered via the portal vein after hepatectomy. Liver regeneration was assessed histopathologically, immunohistochemically and biochemically on postoperative day (POD) 5. PRP treatment significantly increased Ki-67 expression, indicating enhanced hepatocyte proliferation. CGF promoted neovascularization and improved hepatocyte morphology but showed lower Ki-67 expression than PRP. SPx did not significantly enhance regeneration compared to PHx alone. Signal Transducer and Activator of Transcription 3 (STAT3) expression was highest in the PHx group, whereas the PRP and CGF groups exhibited moderate levels. PRP and CGF improved liver function biochemically, reducing bilirubin levels. Both PRP and CGF promote liver regeneration, albeit through distinct mechanisms: PRP primarily enhances cellular proliferation, whereas CGF facilitates vascularization and modulates the immune response. SPx did not confer additional benefits in this model. These findings suggest that PRP and CGF may have potential therapeutic applications in preventing post-hepatectomy liver failure.
- 25 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessThe effects of splenectomy, platelet-rich plasma (PRP) and concentrated growth factor (CGF) on liver regeneration following major hepatectomy in rats
Post-hepatectomy liver failure is a serious complication following liver resection and is associated with high morbidity and mortality. Platelets play a crucial role in liver regeneration due to their rich content of growth factors. However, the comparative effects of platelet-rich plasma (PRP) and concentrated growth factor (CGF) on liver regeneration remain unclear. This study aimed to evaluate and compare the effects of splenectomy (SPx), PRP, and CGF on liver regeneration and function following 70% hepatectomy in rats. Male Wistar rats were randomly divided into six groups: Control, Sham, Hepatectomy (PHx), Hepatectomy + SPx, Hepatectomy + PRP, and PHx + CGF. PRP and CGF were prepared using differential centrifugation and administered via the portal vein after hepatectomy. Liver regeneration was assessed histopathologically, immunohistochemically and biochemically on postoperative day (POD) 5. PRP treatment significantly increased Ki-67 expression, indicating enhanced hepatocyte proliferation. CGF promoted neovascularization and improved hepatocyte morphology but showed lower Ki-67 expression than PRP. SPx did not significantly enhance regeneration compared to PHx alone. Signal Transducer and Activator of Transcription 3 (STAT3) expression was highest in the PHx group, whereas the PRP and CGF groups exhibited moderate levels. PRP and CGF improved liver function biochemically, reducing bilirubin levels. Both PRP and CGF promote liver regeneration, albeit through distinct mechanisms: PRP primarily enhances cellular proliferation, whereas CGF facilitates vascularization and modulates the immune response. SPx did not confer additional benefits in this model. These findings suggest that PRP and CGF may have potential therapeutic applications in preventing post-hepatectomy liver failure.
- 27 February 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (3) , e70283
Refractive Changes Associated With Pediatric Kidney Transplantation
Introduction: Kidney transplantation remains the optimal treatment for children with end‐stage renal disease (ESRD), 25%–40% of which are estimated to be caused by congenital malformations and genetic syndromes. Given the widespread nature of this surgical procedure, ocular complications may arise from the operation itself or from subsequent medical treatments. The aim of this study is to determine whether there are postoperative refractive changes in pediatric patients who have undergone kidney transplantation and to detect the presence of refractive changes that may cause amblyopia in patient follow‐ups. Methods: The electronic medical records of 1144 patients who underwent kidney transplantation at the Akdeniz University Hospital Organ Transplant Center between January 2019 and January 2024 were reviewed retrospectively. Of these, 84 pediatric patients who had undergone a complete ophthalmologic examination at least 1 year after kidney transplantation and had no missing data were included in the study. For both eyes, all data were recorded, including Best Corrected Visual Acuity (BCVA), refractive error (measured with the KR‐8900; Topcon, Tokyo, Japan), spherical equivalent refractions (SER), slit‐lamp examination of the anterior segment, and a dilated fundus examination. Results: The average age of patients who underwent kidney transplantation in the study is 13.01 ± 3.43 (6–18). The average follow‐up period was 51.81 ± 33.5 (45–129) months. Thirty‐five (41.7%) of the patients are female, and 49 (58.3%) are male. Cataracts were observed in 9 (10.7%) patients during follow‐up after transplantation. Cataract development was observed on average in 5.6 years. Posterior subcapsular cataracts were observed in seven patients, cortical cataract in one patient, and anterior polar cataract in one patient. The mean preoperative visual acuity value in patients who developed cataracts after kidney transplantation was 0.00 logMAR, while it was measured as 0.19 logMAR in the postoperative period, and this decrease is statistically significant ( p = 0.027). In patients who did not develop cataracts during the follow‐up period, there was no statistically significant change in visual acuity in both eyes ( p = 0.109). When all eyes are evaluated, the change in SER after kidney transplantation is not statistically significant compared with before ( p = 0.689 for the right eye, p = 0.596 for the left eye). Conclusion: Although children receive longer‐term immunosuppressive treatment, their cataract development rates are lower than those of adults. Despite intensive and prolonged immunosuppression therapy after kidney transplantation, cataract development and refractive changes in the pediatric age group are at an acceptable level. Especially in children who are too young to express themselves clearly, monitoring refractive changes is crucial to prevent permanent vision loss.
- 27 February 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (3) , e70283
Refractive Changes Associated With Pediatric Kidney Transplantation
Introduction: Kidney transplantation remains the optimal treatment for children with end‐stage renal disease (ESRD), 25%–40% of which are estimated to be caused by congenital malformations and genetic syndromes. Given the widespread nature of this surgical procedure, ocular complications may arise from the operation itself or from subsequent medical treatments. The aim of this study is to determine whether there are postoperative refractive changes in pediatric patients who have undergone kidney transplantation and to detect the presence of refractive changes that may cause amblyopia in patient follow‐ups. Methods: The electronic medical records of 1144 patients who underwent kidney transplantation at the Akdeniz University Hospital Organ Transplant Center between January 2019 and January 2024 were reviewed retrospectively. Of these, 84 pediatric patients who had undergone a complete ophthalmologic examination at least 1 year after kidney transplantation and had no missing data were included in the study. For both eyes, all data were recorded, including Best Corrected Visual Acuity (BCVA), refractive error (measured with the KR‐8900; Topcon, Tokyo, Japan), spherical equivalent refractions (SER), slit‐lamp examination of the anterior segment, and a dilated fundus examination. Results: The average age of patients who underwent kidney transplantation in the study is 13.01 ± 3.43 (6–18). The average follow‐up period was 51.81 ± 33.5 (45–129) months. Thirty‐five (41.7%) of the patients are female, and 49 (58.3%) are male. Cataracts were observed in 9 (10.7%) patients during follow‐up after transplantation. Cataract development was observed on average in 5.6 years. Posterior subcapsular cataracts were observed in seven patients, cortical cataract in one patient, and anterior polar cataract in one patient. The mean preoperative visual acuity value in patients who developed cataracts after kidney transplantation was 0.00 logMAR, while it was measured as 0.19 logMAR in the postoperative period, and this decrease is statistically significant ( p = 0.027). In patients who did not develop cataracts during the follow‐up period, there was no statistically significant change in visual acuity in both eyes ( p = 0.109). When all eyes are evaluated, the change in SER after kidney transplantation is not statistically significant compared with before ( p = 0.689 for the right eye, p = 0.596 for the left eye). Conclusion: Although children receive longer‐term immunosuppressive treatment, their cataract development rates are lower than those of adults. Despite intensive and prolonged immunosuppression therapy after kidney transplantation, cataract development and refractive changes in the pediatric age group are at an acceptable level. Especially in children who are too young to express themselves clearly, monitoring refractive changes is crucial to prevent permanent vision loss.
- 17 March 2023
- Published by Springer Nature in International Urology and Nephrology
- Vol. 55 (10) , 2589-2598
Evaluation of the effect and predictive role of vitamin D and vitamin D receptor expression in CD4 + , CD8 + , CD14 + , CD56 + cells on the development of chronic rejection and graft functions in kidney transplant patients
Purpose It is known that vitamin D has positive effects on graft functions (reduce fibrosis, suppress excessive inflammatory response, improve graft functions). In our study, it was aimed to evaluate the effects and predictive roles of vitamin D, the expression of vitamin D receptor (VDR) in lymphocytes, monocytes, natural killer cells on chronic rejection and graft functions in kidney transplant patients. Methods Seventy one people were included in the study and analyses were made by dividing them into 3 groups. Group 1: Healthy control (n = 29), Group 2: Kidney transplant patients with stable kidney function (n = 17), and Group 3: Kidney transplant patients with chronic rejection diagnosis (n = 25). Serum 25-hydroxycholecalciferol, 1.25 dihydroxycholecalciferol levels and VDR percentages in CD4 + , CD8 + , CD14 + , CD56 + cells were measured in 3 groups. ROC analyses and logistic regression models were performed to predict rejection and long-term graft functions. Results The percentage of VDR expression in CD4 + lymphocytes (p < 0.001) and CD14( +) monocytes (p < 0.001), 25-hydroxycholecalciferol and 1.25 dihydroxycholecalciferol levels were lower in group 3 was detected. In ROC analyses and logistic regression models, VDR expression in CD4( +)T lymphocytes was shown to have a statistically significant value in the development of chronic rejection (Odds ratio 0.86: 0.76–0.92; p = 0.001/AUC = 0.941, p < 0.001) and prediction of 5th-year graft functions (Odds ratio 0.93: 0.88–0.98; p = 0.017/AUC = 0.745, p = 0.007). Conclusion In our study, it was shown that low vitamin D and VDR expression is associated with poor outcome and VDR expression in CD4( +)T lymphocytes is predictive in terms of graft function and rejection.
- 17 March 2023
- Published by Springer Nature in International Urology and Nephrology
- Vol. 55 (10) , 2589-2598
Evaluation of the effect and predictive role of vitamin D and vitamin D receptor expression in CD4 + , CD8 + , CD14 + , CD56 + cells on the development of chronic rejection and graft functions in kidney transplant patients
Purpose It is known that vitamin D has positive effects on graft functions (reduce fibrosis, suppress excessive inflammatory response, improve graft functions). In our study, it was aimed to evaluate the effects and predictive roles of vitamin D, the expression of vitamin D receptor (VDR) in lymphocytes, monocytes, natural killer cells on chronic rejection and graft functions in kidney transplant patients. Methods Seventy one people were included in the study and analyses were made by dividing them into 3 groups. Group 1: Healthy control (n = 29), Group 2: Kidney transplant patients with stable kidney function (n = 17), and Group 3: Kidney transplant patients with chronic rejection diagnosis (n = 25). Serum 25-hydroxycholecalciferol, 1.25 dihydroxycholecalciferol levels and VDR percentages in CD4 + , CD8 + , CD14 + , CD56 + cells were measured in 3 groups. ROC analyses and logistic regression models were performed to predict rejection and long-term graft functions. Results The percentage of VDR expression in CD4 + lymphocytes (p < 0.001) and CD14( +) monocytes (p < 0.001), 25-hydroxycholecalciferol and 1.25 dihydroxycholecalciferol levels were lower in group 3 was detected. In ROC analyses and logistic regression models, VDR expression in CD4( +)T lymphocytes was shown to have a statistically significant value in the development of chronic rejection (Odds ratio 0.86: 0.76–0.92; p = 0.001/AUC = 0.941, p < 0.001) and prediction of 5th-year graft functions (Odds ratio 0.93: 0.88–0.98; p = 0.017/AUC = 0.745, p = 0.007). Conclusion In our study, it was shown that low vitamin D and VDR expression is associated with poor outcome and VDR expression in CD4( +)T lymphocytes is predictive in terms of graft function and rejection.
- Open Access
- 1 January 2023
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 55 (3) , 254-258
Evaluation of Overall Survival and Disease-Free Survival in Patients Receiving Liver Transplantation for Hepatocellular Carcinoma and Comparison of Living Versus Deceased Donor Liver Transplants: Results of 15 Years of Experience
Objective: Research comparing patients who received liver transplantation (LT) for hepatocellular carcinoma (HCC) has produced varying outcomes regarding survival and disease-free survival. The objective of this study is to determine the factors that influence the disease-free and overall survivals of those who have undergone LT for HCC and to compare the outcomes of living versus deceased donor liver transplants. Materials and Methods: We retrospectively analyzed data on patients aged 18 and above who received LT for HCC from 2006 to 2022. Patients with a follow-up period of less than 6 months and who did not meet the University of California San Francisco criteria were excluded. The data from 58 patients were analyzed. We split the patients into living donor liver transplantation (LDLT) (group 1) and deceased donor liver transplantation (DDLT) (group 2). Results: The mean age was 56 ± 8.1 years. There were 49 males and 9 females. The median of the alphafetoprotein (AFP) level and model for end-stage liver disease score was 10.1 ng/mL and 11, respectively. The 1-, 3-, 5-, and 10-year disease-free survival rates were 86%, 76.5%, 76.5%, and 76.5%, respectively. The survival rates for the same periods were 94.8%, 74.9%, 70.6%, and 67.4%. The receiver operating characteristic analysis revealed that AFP > 31.8 ng/mL and a total tumor size >3.85 cm raise the likelihood of HCC recurrence post-LT. Conclusion: Based on the current literature, the overall survival and disease-free survival rates are influenced by factors such as AFP value, total tumor number, and total tumor diameter. In our study, the AFP value and total tumor size had an impact on the recurrence of HCC, and the survival rates were comparable on LDLT and DDLT. Cite this article as: Avanaz A, Adanir H, Kisaoglu A, et al. Evaluation of overall survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma and comparison of living versus deceased donor liver transplants: results of 15 years of experience. Eurasian J Med. 2023;55(3):254-258.
- 1 January 2023
- Published by AVES YAYINCILIK A.Ş. in The Eurasian Journal of Medicine
- Vol. 55 (3) , 254-258
Open AccessEvaluation of Overall Survival and Disease-Free Survival in Patients Receiving Liver Transplantation for Hepatocellular Carcinoma and Comparison of Living Versus Deceased Donor Liver Transplants: Results of 15 Years of Experience
Objective: Research comparing patients who received liver transplantation (LT) for hepatocellular carcinoma (HCC) has produced varying outcomes regarding survival and disease-free survival. The objective of this study is to determine the factors that influence the disease-free and overall survivals of those who have undergone LT for HCC and to compare the outcomes of living versus deceased donor liver transplants. Materials and Methods: We retrospectively analyzed data on patients aged 18 and above who received LT for HCC from 2006 to 2022. Patients with a follow-up period of less than 6 months and who did not meet the University of California San Francisco criteria were excluded. The data from 58 patients were analyzed. We split the patients into living donor liver transplantation (LDLT) (group 1) and deceased donor liver transplantation (DDLT) (group 2). Results: The mean age was 56 ± 8.1 years. There were 49 males and 9 females. The median of the alphafetoprotein (AFP) level and model for end-stage liver disease score was 10.1 ng/mL and 11, respectively. The 1-, 3-, 5-, and 10-year disease-free survival rates were 86%, 76.5%, 76.5%, and 76.5%, respectively. The survival rates for the same periods were 94.8%, 74.9%, 70.6%, and 67.4%. The receiver operating characteristic analysis revealed that AFP > 31.8 ng/mL and a total tumor size >3.85 cm raise the likelihood of HCC recurrence post-LT. Conclusion: Based on the current literature, the overall survival and disease-free survival rates are influenced by factors such as AFP value, total tumor number, and total tumor diameter. In our study, the AFP value and total tumor size had an impact on the recurrence of HCC, and the survival rates were comparable on LDLT and DDLT. Cite this article as: Avanaz A, Adanir H, Kisaoglu A, et al. Evaluation of overall survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma and comparison of living versus deceased donor liver transplants: results of 15 years of experience. Eurasian J Med. 2023;55(3):254-258.
- 1 January 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (3) , e14464
Long‐term results of liver transplantation for maple syrup urine disease: A single‐center experience in Turkey
Objectives: Maple syrup urine disease (MSUD) is an autosomal recessive inherited disorder. Despite the advances in medical nutrition therapies, classical phenotype causes severe neurological disorders and sudden death. It is known that MSUD patients do not experience metabolic attacks despite their free diet after liver transplantation (LT). This study aims to reveal the long‐term results, development, mental, motor, intellectual and nutritional status of MSUD patients who underwent LT.Methods: The data of 12 patients who underwent deceased donor (5 recipients) and living donor liver transplantation (7 recipients) were retrospectively analyzed. The age, genotype, psychometric and mental status, development, BCAA values, type of LT, donor‐recipient proximity, complications, and survival were assessed.Results: There were 4 (33%) girls and 8 (67%) boys. The mean current age was 9.33 ± 4.58 years. The mean follow‐up time was 3 ± 2.5 years. The repeated measures of leucine and isoleucine values revealed that there were no significant differences from the pre‐LT to post‐LT 1‐year. The protein‐restricted nutrition was switched to a free diet when oral intake was opened after LT. None of the recipients experienced metabolic attacks after the living donor or deceased donor LT. The 1‐, 3‐, and 5‐year survival rate of the patients is 83.3%. There was no significant difference in survival between living and deceased donor liver transplantation.Conclusions: Liver transplantation is a treatment option for MSUD in proper conditions to save the patient life, increase the quality of life, and provide essential amino acids with free diet intake for growth and development.
- 1 January 2023
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (3) , e14464
Long‐term results of liver transplantation for maple syrup urine disease: A single‐center experience in Turkey
Objectives: Maple syrup urine disease (MSUD) is an autosomal recessive inherited disorder. Despite the advances in medical nutrition therapies, classical phenotype causes severe neurological disorders and sudden death. It is known that MSUD patients do not experience metabolic attacks despite their free diet after liver transplantation (LT). This study aims to reveal the long‐term results, development, mental, motor, intellectual and nutritional status of MSUD patients who underwent LT.Methods: The data of 12 patients who underwent deceased donor (5 recipients) and living donor liver transplantation (7 recipients) were retrospectively analyzed. The age, genotype, psychometric and mental status, development, BCAA values, type of LT, donor‐recipient proximity, complications, and survival were assessed.Results: There were 4 (33%) girls and 8 (67%) boys. The mean current age was 9.33 ± 4.58 years. The mean follow‐up time was 3 ± 2.5 years. The repeated measures of leucine and isoleucine values revealed that there were no significant differences from the pre‐LT to post‐LT 1‐year. The protein‐restricted nutrition was switched to a free diet when oral intake was opened after LT. None of the recipients experienced metabolic attacks after the living donor or deceased donor LT. The 1‐, 3‐, and 5‐year survival rate of the patients is 83.3%. There was no significant difference in survival between living and deceased donor liver transplantation.Conclusions: Liver transplantation is a treatment option for MSUD in proper conditions to save the patient life, increase the quality of life, and provide essential amino acids with free diet intake for growth and development.
- 14 April 2022
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 42 (4) , 250-259
Comparison of tomographic kidney volumes measured by semiautomatic segmentation method with scintigraphic split renal function in predicting posttransplant kidney functions
Introduction: In this study, it was aimed to compare scintigraphic split renal function (SRF) and computed tomographic (CT) kidney volumes by semiautomatic segmentation method in predicting graft functions after kidney transplantation.Methods: One hundred and twelve patients (77 males, 35 females) who had a living‐donor kidney transplant between 2015 and 2017 in our centre were included in the study. While SRF was calculated with technetium‐99m‐diethylenetriaminepentaacetic acid (99mTc‐DTPA) scintigraphy, CT angiography was used for volumetric calculations.Results: CT‐volumetric measurements, especially renal cortical volume (RCV: 103.8 ± 20 ml) and ratio to body mass index (RCV/BMI: 4.45 ± 1.3) were found to be more significant than 99mTc‐DTPA‐SRF in predicting graft functions. The correlations between SRF and RCV with 6th‐month estimated glomerular filtration rate (eGFR) (rSRF: 0.052, rRCV: 0.317, p = 0.041) and 1st‐year eGFR (rSRF: 0.104, rRCV: 0.374, p = 0.033) were found to be more significant in favour of RCV. The correlation between SRF/BMI and RCV/BMI with 1st‐, 6th‐ and 12th‐month eGFR (respectively, p = 0.02/0.048/0.024) were found to be more significant in favour of RCV/BMI. Although univariate analysis showed a significant relationship between most volumetric measurements and 1st‐year graft functions, in multivariate analysis only RCV [odds ratio (OR): 1.04 (1.01–1.07), p = 0.023] and RCV/BMI [OR: 2.5 (1.27–5.39), p = 0.013] showed a significant relationship between graft functions.Conclusion: In our study, it was shown that CT‐based renal volumetric measurements, especially RCV and RCV/BMI, predicted graft functions more strongly than scintigraphic 99mTc‐DTPA‐SRF.
- 14 April 2022
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 42 (4) , 250-259
Comparison of tomographic kidney volumes measured by semiautomatic segmentation method with scintigraphic split renal function in predicting posttransplant kidney functions
Introduction: In this study, it was aimed to compare scintigraphic split renal function (SRF) and computed tomographic (CT) kidney volumes by semiautomatic segmentation method in predicting graft functions after kidney transplantation.Methods: One hundred and twelve patients (77 males, 35 females) who had a living‐donor kidney transplant between 2015 and 2017 in our centre were included in the study. While SRF was calculated with technetium‐99m‐diethylenetriaminepentaacetic acid (99mTc‐DTPA) scintigraphy, CT angiography was used for volumetric calculations.Results: CT‐volumetric measurements, especially renal cortical volume (RCV: 103.8 ± 20 ml) and ratio to body mass index (RCV/BMI: 4.45 ± 1.3) were found to be more significant than 99mTc‐DTPA‐SRF in predicting graft functions. The correlations between SRF and RCV with 6th‐month estimated glomerular filtration rate (eGFR) (rSRF: 0.052, rRCV: 0.317, p = 0.041) and 1st‐year eGFR (rSRF: 0.104, rRCV: 0.374, p = 0.033) were found to be more significant in favour of RCV. The correlation between SRF/BMI and RCV/BMI with 1st‐, 6th‐ and 12th‐month eGFR (respectively, p = 0.02/0.048/0.024) were found to be more significant in favour of RCV/BMI. Although univariate analysis showed a significant relationship between most volumetric measurements and 1st‐year graft functions, in multivariate analysis only RCV [odds ratio (OR): 1.04 (1.01–1.07), p = 0.023] and RCV/BMI [OR: 2.5 (1.27–5.39), p = 0.013] showed a significant relationship between graft functions.Conclusion: In our study, it was shown that CT‐based renal volumetric measurements, especially RCV and RCV/BMI, predicted graft functions more strongly than scintigraphic 99mTc‐DTPA‐SRF.
- Open Access
- 24 December 2021
- Published by Elsevier in Asian Journal of Surgery
- Vol. 45 (11) , 2239-2245
Impact of older age on the long-term survival in living-donor liver transplantation: A propensity score matching analysis
- 24 December 2021
- Published by Elsevier in Asian Journal of Surgery
- Vol. 45 (11) , 2239-2245
Open AccessImpact of older age on the long-term survival in living-donor liver transplantation: A propensity score matching analysis
- 4 January 2021
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 190 (4) , 1539-1545
Effect of post-perfusion hyperoxemia on early graft function in renal transplant recipients: a retrospective observational cohort study
Background The effects of hyperoxemia on the transplanted grafts arouse interest nowadays, particularly intraoperative hyperoxemia, on transplant kidney function and survival in the 1-year post-operative period. Aims We aimed to investigate the effect of post-perfusion (5 min after perfusion) hyperoxemia on early graft function and survival in renal transplant recipients. Methods Two hundred forty-seven living donor kidney transplant recipients were included in the study. Patients were divided into the three groups according to their partial arterial oxygen pressure in post-perfusion blood gas samples: group 1: normoxia (n = 52, PaO2 pressure: < 120 mmHg, 103 ± 13); group 2: moderate hyperoxemia (n = 121, PaO2: 120–200 mmHg, 169 ± 21); group 3: severe hyperoxemia (n = 74, PaO2: > 200 mmHg, 233 ± 25). Graft functions (serum creatinine levels, estimated-glomerular filtration rate values, spot urine protein/creatinine ratio), survival rates, and groups’ clinical outcomes were compared in the first year after transplantation. Results Graft survival rates were similar in the groups and the rate of BK virus viremia was the lowest in the group 3 (groups 1, 2, and 3: 15.4% (n = 8), 6.6% (n = 8), 1.4% (n = 1), respectively, P: 0.009). Serum creatinine and proteinuria levels were lower, and estimated-glomerular filtration rate values were higher in group 3. A negative correlation between partial arterial oxygen pressure and serum creatinine levels and a positive correlation with estimated-glomerular filtration rate value were noted. These results were confirmed by univariate and multivariate analyses. Conclusions We demonstrated that the kidney transplant recipients with post-perfusion hyperoxemia have better early graft functions and lower BK virus viremia rates. Trial registration ClinicalTrials.gov Identifier: NCT04420897
- 4 January 2021
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 190 (4) , 1539-1545
Effect of post-perfusion hyperoxemia on early graft function in renal transplant recipients: a retrospective observational cohort study
Background The effects of hyperoxemia on the transplanted grafts arouse interest nowadays, particularly intraoperative hyperoxemia, on transplant kidney function and survival in the 1-year post-operative period. Aims We aimed to investigate the effect of post-perfusion (5 min after perfusion) hyperoxemia on early graft function and survival in renal transplant recipients. Methods Two hundred forty-seven living donor kidney transplant recipients were included in the study. Patients were divided into the three groups according to their partial arterial oxygen pressure in post-perfusion blood gas samples: group 1: normoxia (n = 52, PaO2 pressure: < 120 mmHg, 103 ± 13); group 2: moderate hyperoxemia (n = 121, PaO2: 120–200 mmHg, 169 ± 21); group 3: severe hyperoxemia (n = 74, PaO2: > 200 mmHg, 233 ± 25). Graft functions (serum creatinine levels, estimated-glomerular filtration rate values, spot urine protein/creatinine ratio), survival rates, and groups’ clinical outcomes were compared in the first year after transplantation. Results Graft survival rates were similar in the groups and the rate of BK virus viremia was the lowest in the group 3 (groups 1, 2, and 3: 15.4% (n = 8), 6.6% (n = 8), 1.4% (n = 1), respectively, P: 0.009). Serum creatinine and proteinuria levels were lower, and estimated-glomerular filtration rate values were higher in group 3. A negative correlation between partial arterial oxygen pressure and serum creatinine levels and a positive correlation with estimated-glomerular filtration rate value were noted. These results were confirmed by univariate and multivariate analyses. Conclusions We demonstrated that the kidney transplant recipients with post-perfusion hyperoxemia have better early graft functions and lower BK virus viremia rates. Trial registration ClinicalTrials.gov Identifier: NCT04420897
- 1 August 2019
- Published by Baskent University in Experimental and Clinical Transplantation
- Vol. 17 (4) , 568-570
Cardiac Tamponade Due to Pneumopericardium After Liver Transplant
Pneumopericardium is a rare cause of cardiac tamponade, and it is an extremely rare complication of liver transplant. Here, we present a patient with cryptogenic liver cirrhosis who experienced cardiac tamponade secondary to a tension pneumopericardium during the postoperative course after liver transplant.
- 1 August 2019
- Published by Baskent University in Experimental and Clinical Transplantation
- Vol. 17 (4) , 568-570
Cardiac Tamponade Due to Pneumopericardium After Liver Transplant
Pneumopericardium is a rare cause of cardiac tamponade, and it is an extremely rare complication of liver transplant. Here, we present a patient with cryptogenic liver cirrhosis who experienced cardiac tamponade secondary to a tension pneumopericardium during the postoperative course after liver transplant.